首页> 外文期刊>Graefe's Archive for Clinical and Experimental Ophthalmology >Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up
【24h】

Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up

机译:单次光动力疗法联合维替泊芬联合玻璃体内抗血管内皮生长因子疗法治疗慢性中央性浆液性脉络膜视网膜病变:12个月随访的初步研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background To report the anatomic and functional outcomes of a single-session combined photodynamic therapy with verteporfin (PDT) and intravitreal (IVT) anti-vascular endothelial growth factor (anti-VEGF) in patients with chronic central serous chorioretinopathy (CCSCR).
机译:背景研究报告在慢性中央性浆液性脉络膜脉络膜视网膜病变(CCSCR)患者中,单次联合光动力疗法联合维替泊芬(PDT)和玻璃体内(IVT)抗血管内皮生长因子(anti-VEGF)的解剖学和功能结局。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号